New specialised treatment for high-risk neuroblastomas.

The Clinical and Traslational Research Group in Pediatric Oncology (GICT -OP) is looking for tailor-made treatments for neuroblastoma with the least favourable prognosis. The goal is to obtain an individualised treatment through a personalised and very precise medicinal approach for each of the children according to the characteristics of their tumor.

Ayudan a hacer posible este proyecto:

Make a donation

What amount would you like to donate?
How would you like to donate?